Kaleido Biosciences Inc

NASDAQ:KLDO  
6.32
+0.50 (+8.59%)
Earnings Announcements

Kaleido Biosciences Reports Q1 Loss Per Share Of $0.58

Published: 05/04/2021 12:11 GMT
Kaleido Biosciences Inc (KLDO) - Kaleido Biosciences Reports First Quarter 2021 Financial Results.
Q1 Loss per Share $0.58.
Quarterly Loss per Share $0.58.
Revenue is expected to be $0.09 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0.09 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.